Search

Your search keyword '"Posner MP"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Posner MP" Remove constraint Author: "Posner MP"
99 results on '"Posner MP"'

Search Results

2. Use of extracorporeal membrane oxygenation for adult respiratory distress syndrome following cadaveric renal transplantation

4. Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients.

5. Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation.

6. Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.

7. Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study.

8. The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis.

9. Outcomes of kidney transplants and risk of infection transmission from increased infectious risk donors.

10. Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.

11. Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction.

12. Multimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.

13. Quantifying the risk of incompatible kidney transplantation: a multicenter study.

14. Commercial surrogacy: how provisions of monetary remuneration and powers of international law can prevent exploitation of gestational surrogates.

15. Graft-versus-host disease after solid organ transplantation: a single center experience and review of literature.

16. Identification of biomarkers to assess organ quality and predict posttransplantation outcomes.

17. Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation.

18. Reduced expression of inflammatory genes in deceased donor kidneys undergoing pulsatile pump preservation.

19. En bloc kidney transplantation from pediatric donors: comparable outcomes with living donor kidney transplantation.

20. Gene expression changes are associated with loss of kidney graft function and interstitial fibrosis and tubular atrophy: diagnosis versus prediction.

21. Pretransplant transcriptome profiles identify among kidneys with delayed graft function those with poorer quality and outcome.

22. Distinctive gene expression profiles characterize donor biopsies from HCV-positive kidney donors.

23. Living donor liver transplantation for neonatal hemochromatosis using non-anatomically resected segments II and III: a case report.

24. Saphenous vein graft aneurysm after renal transplantation: a case report.

25. Adult living donor versus deceased donor liver transplantation: a 10-year prospective single center experience.

26. Effect of hyponatraemia on outcomes following orthotopic liver transplantation.

27. Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes.

28. Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis.

29. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome.

30. Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years.

31. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.

32. Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival.

33. Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience.

34. Molecular markers in stored kidneys using perfluorocarbon-based preservation solution: preliminary results.

35. Adult living donor versus deceased donor liver transplantation: a 6-year single center experience.

36. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.

37. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.

38. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.

39. Massive hepatic artery atherosclerosis of an otherwise suitable donor liver: a case report.

40. Reasons for non-use of recovered kidneys: the effect of donor glomerulosclerosis and creatinine clearance on graft survival.

41. Hardikar syndrome: a case requiring liver transplantation.

42. Prospective validation of quantitative polymerase chain reaction for management of cytomegalovirus disease in solid-organ transplant patients.

43. Calcineurin inhibitor-induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent.

44. Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation.

45. The interrelationship between portal and arterial blood flow after adult to adult living donor liver transplantation.

46. Selection and outcome of living donors for adult to adult right lobe transplantation.

47. Surgical management of anatomical variations of the right lobe in living donor liver transplantation.

48. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure.

49. Emergency portacaval shunt for control of hemorrhage from a parenchymal fracture after adult-to-adult living donor liver transplantation.

50. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe.

Catalog

Books, media, physical & digital resources